| Date |
Title |
|
| 2006 |
| 12/06/06 |
Investigator in Phase I Clinical Trial for Batten Disease to Present at Lysosomal Disease Network World Symposium |
| 12/05/06 |
StemCells, Inc. Announces Key Executive Appointments |
| 11/15/06 |
StemCells, Inc. Announces First Human Neural Stem Cell Transplant |
| 11/01/06 |
StemCells Announces Third Quarter 2006 Financial Results |
| 10/27/06 |
StemCells, Inc. to Present at the Rodman & Renshaw 8th Annual Healthcare Conference Conference |
| 9/21/06 |
StemCells, Inc. to Present at UBS Global Life Sciences Conference |
| 8/29/06 |
StemCells, Inc. Grants License to Stem Cell Therapeutics |
| 8/1/06 |
StemCells Announces Second Quarter 2006 Financial Results |
| 7/20/06 |
StemCells, Inc. to Present Preclinical Data Showing Engraftment of Human Liver-Derived Cells at the World Transplant Congress |
| 7/10/06 |
StemCells, Inc. to Present at C. E. Unterberg, Towbin Emerging Growth Opportunities Conference |
| 6/27/06 |
StemCells, Inc. to Present at the International Society for Stem Cell Research Annual Meeting |
| 4/28/06 |
StemCells Announces First Quarter 2006 Financial Results |
| 4/10/06 |
StemCells, Inc. Names Elizabeth Leininger Vice President, Regulatory Affairs and Quality Assurance |
| 4/7/06 |
StemCells, Inc. Announces Closing of $35.8 Million Financing |
| 4/3/06 |
StemCells Announces Sale of Common Stock |
| 3/16/06 |
StemCells Announces Fourth Quarter and Year End 2005 Financial Results |
| 3/09/06 |
StemCells, Inc. Receives IRB Approval From Oregon Health & Science University To Begin Phase I Clinical Trial In Batten Disease |
| 3/06/06 |
StemCells, Inc. to Present at Cowen & Co. 26th Annual Health Care Conference |
| 1/10/06 |
StemCells, Inc. Names Maria Millan, M.D., F.A.C.S., to Lead Its Liver Cell Transplant Program |
|
ˆTop
|
| 2005 |
| 12/06/05 |
StemCells, Inc. to Present at Harris Nesbitt Focus on Healthcare Conference |
| 11/15/05 |
StemCells, Inc. Added to NASDAQ Biotechnology Index® |
| 11/04/05 |
StemCells, Inc. to Participate in Stem Cell Research Challenges Conference |
| 11/03/05 |
StemCells, Inc. to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference |
| 10/28/05 |
StemCellsAnnounces Third Quarter 2005 Financial Results |
| 10/20/05 |
StemCells, Inc. Receives FDA Clearance to Initiate Phase I Clinical Trial of Neural Stem Cells to Treat Batten Disease |
| 10/18/05 |
StemCells, Inc. to Present at BIO InvestorForum |
| 09/30/05 |
StemCells, Inc. Moves to NASDAQ National Market |
| 09/20/05 |
StemCells, Inc. to Present at UBS Global Life Sciences Conference |
| 09/19/05 |
Published Study Shows First Direct Link Between Human Neural Stem Cells and Restored Motor Function in Spinal Cord Injured Mice |
| 09/19/05 |
StemCells Files IND Amendment for Human Neural Stem Cell Transplant Treatment for Batten Disease |
| 09/07/05 |
StemCells Appoints Rodney K.B. Young CFO and VP, Finance |
| 08/31/05 |
StemCells Receives Manufacturing License for Cell Processing Facility in California |
| 07/29/05 |
StemCells Announces Second Quarter 2005 Financial Results |
| 07/06/05 |
StemCells, Inc. Grants License to ReNeuron |
| 06/29/05 |
StemCells, Inc. Added to Russell 3000® Index |
| 06/09/05 |
StemCells, Inc. to Present at Morgan Stanley Small Cap Executive Conference |
| 05/02/05 |
StemCells Announces First Quarter 2005 Financial Results |
| 03/31/05 |
StemCells, Inc. Issues FDA Update on Proposed Clinical Trial |
| 03/04/05 |
StemCells Announces Fourth Quarter and Year End 2004 Financial Results |
| 02/28/05 |
StemCells, Inc. Names Alan Jacobs Chief Medical Officer and Vice President of Clinical Research, Neural Program |
| 02/01/05 |
StemCells, Inc. Announces Communications with FDA on Proposed Phase I Clinical Trial |
| 01/04/05 |
StemCells, Inc. Announces Filing of IND for Human Neural Stem Cell Transplant Treatment for Batten Disease |
|
ˆTop
|
| 2004 |
| 11/08/04 |
StemCells Appoints Judi R. Lum CFO and VP, Finance |
| 11/04/04 |
StemCells Comments on Passage of California Proposition 71; Company Supports Stem Cell Research and Cures Initiative |
| 11/04/04 |
CEO's interview with Bloomberg TV
High Quality (8mb)
Low Quality (3mb)
Requires Windows Media Player |
| 11/01/04 |
StemCells Completes Equity Financing; $22.5 Million in Funds to Support Batten's Trial |
| 10/26/04 |
StemCells Raises $22.5 Million in New Equity Financing |
| 10/26/04 |
StemCells Announces Third Quarter 2004 Financial Results |
| 10/13/04 |
StemCells to Present at Investment and Scientific Conference |
| 09/20/04 |
StemCells Technology Furthers Research into Alzheimer's Disease and Spinal Cord Injuries |
| 08/23/04 |
StemCells, Inc. Granted U.S. Patent for Human Neural Stem Cell Compositions |
| 07/30/04 |
StemCells Announces Second Quarter 2004 Financial Results |
| 07/28/04 |
StemCells' Human Neural Stem Cells Survive, Migrate and Differentiate in Pre- Clinical Stroke Study |
| 06/17/04 |
StemCells Raises $20 Million in New Equity Financing |
| 06/01/04 |
StemCells To Present at BIO 2004 International Convention |
| 05/04/04 |
StemCells Announces First Quarter 2004 Financial Results |
| 04/06/04 |
StemCells Announces Fourth Quarter and Year End 2003 Financial Results |
| 03/03/04 |
StemCells Elects Eric H. Bjerkholt to Board of Directors |
| 02/20/04 |
StemCells, Inc. to Present at Annual BIO CEO & Investor Conference |
|
ˆTop
|
| 2003 |
| 12/10/03 |
StemCells Raises $9.5 Million in New Financing. |
| 12/09/03 |
StemCells, Inc. retains accounting firm Grant Thornton as new independant auditor. |
| 11/17/03 |
StemCells Inc. Announces Key Research and Development Appointments |
| 11/11/03 |
StemCells, Inc. Announces Conversion of Convertible Preferred Stock and Receipt of $1.6 Million from Warrant Exercise |
| 11/07/03 |
StemCells Inc. Preclinical Data Offers Hope for Multiple Sclerosis and Spinal Cord Injury |
| 10/22/03 |
StemCells reports Financial Results for third quarter of 2003 |
| 10/14/03 |
StemCells, Inc. to Present at Fifth Annual Rodman & Renshaw TechVest Healthcare Conference |
| 09/17/03 |
StemCells Grants License to StemCell Technologies, Inc., a Canadian company, for Research Use of Murine Neural Stem Cells |
| 09/15/03 |
StemCells, Inc. to Present at Annual UbS Warburg Global Life Sciences Conference |
| 09/08/03 |
StemCells, Inc. Receives Grant to Continue Development of Human Neural Stem Cells as Treatment for Spinal Cord Injuries |
| 08/05/03 |
StemCells reports Financial Results for second quarter of 2003. New European Patents Issued |
| 05/16/03 |
StemCells reports Financial Results for first quarter of 2003. |
| 05/13/03 |
StemCells to Raise $6.5 Million in a Private Placement. |
| 05/02/03 |
StemCells Inc. Announces Study Results Using Human Neural Stem Cells as a Treatment for Spinal Cord Injuries. |
| 04/11/03 |
StemCells, Inc. presents preclinical proof of concept for treatment of batten Disease, a fatal neurological disorder. |
| 04/04/03 |
StemCells, Inc. receives U.S. Patent for methods of isolating precursors to insulin producing cells. |
| 04/01/03 |
StemCells Announces Fourth Quarter and Year End 2002 Financial Results |
| 03/31/03 |
10Q: StemCells INC |
| 02/26/03 |
StemCells Inc. Presentation at RedChip Partners boston Conference 2003
(Windows Media Player Required, Audio only) |
| 01/08/03 |
U.S. Patent Office grants StemCells, Inc. 3 neural stem cell patents, including first patent for transplantation of human neural stem cells |
|
ˆTop
|
| 2002 |
| 12/20/02 |
StemCells Moves to Nasdaq SmallCap Market |
| 11/14/02 |
StemCells Announces Third Quarter 2002 Financial Results |
| 11/14/02 |
10-Q: StemCells INC |
| 11/06/02 |
StemCells' Human Neural Stem Cells Show Promise in Pilot PreClinical Stroke Study |
| 11/01/02 |
StemCells Inc. Announces Change in board of Directors |
| 10/15/02 |
CEO Martin McGlynn to Present at Techvest's 4th Annual Healthcare Conference |
| 09/23/02 |
StemCells Inc. Initiates Cost Reduction Program Focuses on Development of Neural and Liver Cells |
| 08/02/02 |
StemCells, Inc. Announces Second Quarter 2002 Financial Results
|
| 07/08/02 |
StemCells Announces Changes in board of Directors
|
| 06/28/02 |
StemCells Grants License to BioWhittaker for Human Neural Stem Cells For Research Use
|
| 05/06/02 |
StemCells Announces First Quarter 2002 Financial Results and Decision to Increase Number of Authorized Shares
|
| 03/06/02 |
StemCells, Inc. Reports Fourth Quarter and Year End 2001 Results
|
| 02/05/02 |
World Stem Cell Research Community to Convene At February 25026 Conference To Assess Scientific and Commercial Opportunities
|
|
ˆTop
|
| 2001 |
| 12/06/01 |
StemCells Cancels Warrants Issued to Millennium; Raises $5 Million in New Financing
|
| 11/08/01 |
StemCells, Inc. Announces Third Quarter 2001 Financial Results
|
| 10/09/01 |
NIH Awards StemCells, Inc. Grant for Liver Research
|
| 10/03/01 |
StemCells Elects Ricardo Levy to Its board of Directors
|
| 08/13/01 |
StemCells, Inc. Announces Second Quarter 2001 Financial Results
|
| 06/22/01 |
StemCells, Inc Announces Financing Transaction
|
| 06/07/01 |
StemCells, Inc. Announces Issuance of Two Patents; Neural and Pancreas Stem Cell Portfolios Increased
|
| 05/11/01 |
StemCells, Inc. Secures Equity Line Financing of Up to $30,000,000
|
| 05/10/01 |
StemCells, Inc. Announces First Quarter 2001 Financial Results
|
| 05/01/01 |
StemCells, Inc. Places All Remaining Modex Therapeutics Founder's Stock; Shares Sold in Private Placement
|
| 04/03/01 |
StemCells, Inc. Reports Fourth Quarter and Year End 2000 Results
|
| 03/01/01 |
StemCells, Inc. Announces Receipt of NIH Funding
|
| 02/26/01 |
StemCells, Inc. Announces Move to Expanded Facilities, Board Changes
|
| 01/10/01 |
StemCells, Inc. Sells Modex Therapeutics, Ltd. Shares
|
| 01/04/01 |
StemCells, Inc. Names Martin McGlynn New President and Chief Executive Officer; Former Pharmadigm CEO to Lead Executive Management Team Effective January 15, 2001
|
|
ˆTop
|
| 2000 |
| 12/20/00 |
StemCells, Inc. Announces board Changes, Publication on SelfRenewal and Transplantation of Neural Stem Cells
|
| 11/14/00 |
StemCells, Inc. Reports Third Quarter Financial Results
|
| 11/1/00 |
First Identification of Purified blood Stem Cells as a Source of Mature Liver Cells Published in Nature Medicine
|
| 09/22/00 |
StemCells, Inc. Plans Management Change
|
| 08/30/00 |
StemCells CEO To Address Investors Online At Stem Cells Forum Thursday, 08ust 31
|
| 08/15/00 |
StemCells, Inc. Releases Second Quarter Financial Results
|
| 08/07/00 |
StemCells, Inc. Announces Private Placement
|
| 05/24/00 |
CytoTherapeutics, Inc. Announces Name Change to StemCells, Inc.
|
| 05/15/00 |
CytoTherapeutics Announces First Quarter Financial Results; Shareholder Equity Increases 110%, Current and Total Liabilities 12rease 60%
|
| 04/19/00 |
Scientists at StemCells California, Inc. Report the First Identification of Purified blood Stem Cells as a Source of Mature Liver Cells
|
| 04/17/00 |
CytoTherapeutics Reports Fourth Quarter and Year End 1999 Results
|
| 03/16/00 |
CytoTherapeutics Announces Settlements With Genentech, Rhode Island Partnership for Science and Technology And Industrial Recreational building Authority
|
| 01/31/00 |
CytoTherapeutics Announces Management Changes
|
| 01/20/00 |
CytoTherapeutics Subsidiary StemCells, Inc. Announces First Direct Isolation of Human brain Stem Cells; Scientists At StemCells, Inc. Report breakthrough At Keystone Symposium Today
|
| 01/03/00 |
CytoTherapeutics Sells Encapsulated Cell Technology To Neurotech S.A.
|
|
ˆTop
|
| 1999 |
| 11/02/99 |
CytoTherapeutics' Researchers First to Directly Isolate Normal Human Neural Stem Cells; Key Step Toward Clinical Application of Proprietary Stem Cell Technology
|
| 10/05/99 |
CytoTherapeutics' Proprietary Stem Cell Technology Featured in Documentary Program Produced in England
|
| 08/16/99 |
CytoTherapeutics Reports Second Quarter Results
|
| 08/02/99 |
CytoTherapeutics' Study in Experimental Neurology Demonstrates Proprietary Methods for Human Neural Stem/Progenitor Cell Lines
|
| 07/23/99 |
Donald Kennedy Joins board At CytoTherapeutics; Former FDA Commissioner and President Emeritus of Stanford University
|
| 07/15/99 |
CytoTherapeutics' Study in the Journal of Neuroscience Demonstrates Successful Transplantation of Human Neural Stem/Progenitor Cells in Preclinical Model
|
| 07/09/99 |
CytoTherapeutics Restructures to Pursue Development of Its Proprietary Stem Cell Technology Platform
|
| 06/24/99 |
CytoTherapeutics Announces Results From Pain Control Implant Phase II Efficacy Study; Collaboration to Commercialize Encapsulated bovine Cell Therapy for Pain Ends
|
| 05/13/99 |
CytoTherapeutics Reports First Quarter Results
|
| 04/28/99 |
Patrick Aebischer Resigns From CytoTherapeutics' board
|
| 02/18/99 |
CytoTherapeutics Reports 1998 YearEnd Financial Results
|
|
ˆTop
|
| 1998 |
| 12/22/98 |
U.S. Patent Office Issues CytoTherapeutics' Human Neural Stem Cell Patent; Used To Develop Treatments For Central Nervous System Disorders
|
| 12/21/98 |
CytoTherapeutics Obtains Exclusive, Worldwide Licenses To Technology For Discovering Pancreatic Stem/Progenitor Cells
|
| 11/09/98 |
CytoTherapeutics' Patent Allowed For Encapsulated Cell Delivery Of Therapeutics To Treat The Eye
|
| 11/06/98 |
CytoTherapeutics Researchers Demonstrate Potential For Human Neural Stem Cells To Repair Or Replace CNS Tissue
|
| 10/30/98 |
CytoTherapeutics Reports Third Quarter Results
|
| 08/03/98 |
CytoTherapeutics Reports Second Quarter Results
|
| 07/31/98 |
CytoTherapeutics, Inc. Adopts Shareholder Rights Plan
|
| 07/24/98 |
York Resigns As Executive Vice President Of CytoTherapeutics' Ophthalmics Program
|
| 06/15/98 |
CytoTherapeutics And Astra Resume Phase IIb Clinical Trial Of Pain Control Implant
|
| 05/27/98 |
CytoTherapeutics Genentech Pact Ends
|
| 05/04/98 |
CytoTherapeutics Reports First Quarter Results
|
| 04/23/98 |
CytoTherapeutics Appoints Billie M. York Executive Vice President Of Opthalmics
|
| 04/09/98 |
CytoTherapeutics Restructures board Of Directors
|
| 01/15/98 |
CytoTherapeutics Reports On Status Of Clinical Trials
|
|
ˆTop
|
| 1997 |
| 09/26/97 |
CytoTherapeutics Acquires StemCells, Inc.
|
| 07/28/97 |
CytoTherapeutics Reports Second Quarter Results
|
| 05/06/97 |
CytoTherapeutics Reports First Quarter Results
|
|
ˆTop
|
| 1996 |
| 11/01/96 |
CytoTherapeutics Reports Third Quarter Results
|
| 07/30/96 |
CytoTherapeutics Reports Second Quarter Results
|
| 05/21/96 |
Peter K. Simon Joins board At CytoTherapeutics
|
| 04/24/96 |
CytoTherapeutics Reports First Quarter Results
|
| 02/05/96 |
Patrick Aebischer M.D., Ph.D. Joins board At CytoTherapeutics
|
| 01/22/96 |
CytoTherapeutics Reports Year - End Results |
|
ˆTop
|
